Office of Science Financial Assistance Program (DOE)

2019 ◽  
Vol 43 (4) ◽  
pp. 3-3
Keyword(s):  
Financial Assistance ◽  
Assistance Program

STRATEGI PENGEMBANGAN DAN ANALISIS SWOT PADA PT. GARUDA INDONESIA TBK

2021 ◽  
Vol 15 (2) ◽  
pp. 179-190
Author(s):  
Nely Supeni ◽  
Wiwik Fitria Ningsih
Keyword(s):  
Swot Analysis ◽  
Financial Assistance ◽  
Literature Study ◽  
Diversification Strategy ◽  
Strategy Analysis ◽  
Assistance Program ◽  
Financial Condition ◽  
Operational Costs ◽  
The World ◽  
The Government

The purpose of this research is to plan a creative and workable strategy for PT. Garuda Indonesia Tbk in an effort to respond to competition in the aviation market. This type of research is descriptive qualitative. Methods of data collection using literature study and data analysis used is a SWOT analysis. Based on the analysis of the Cartesian diagram shows that PT. Garuda Indonesia Tbk is included in quadrant II, which is supporting the Diversification strategy. The result of SO strategy analysis is that PT. Garuda Tbk must maximize the government's financial assistance program to restore the company's financial condition as well as to maintain the company's big name. The results of the ST strategy analysis are PT. Garuda Indonesia Tbk must maintain excellent facilities and services in order to face other aviation competitors. The results of the WO strategy analysis, namely the existence of a financial assistance program from the government, can also be used to improve the competence of company human resources. The results of the WT strategy analysis, namely PT. Garuda Indonesia Tbk must reduce operational costs while maintaining quality in order to be able to compete in the world of aviation.

Barriers to Acquiring Assistive Technology: Cost and Lack of Information

1992 ◽  
Vol 86 (9) ◽  
pp. 402-407 ◽  
Author(s):  
M.M. Uslan
Keyword(s):  
Assistive Technology ◽  
Visually Impaired ◽  
Financial Assistance ◽  
Service Organizations ◽  
Direct Service ◽  
Assistance Program ◽  
Telephone Surveys ◽  
Assistance Programs ◽  
Lack Of Information ◽  
Visually Impaired Persons

This article discusses two major obstacles that visually impaired persons face when considering the purchase of assistive technology—cost and lack of information about technology and financial assistance programs. The results of a survey of direct service organizations and three telephone surveys of visually impaired persons are presented to document the problem. Implications for administrators who wish to develop a financial assistance program are discussed.

Outcomes among minority patients with stage IV colorectal cancer in the Harris County Health System.

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. e18039-e18039
Author(s):  
Kelsey S. Lau-Min ◽  
Preeti Prakash ◽  
Aaron Thrift ◽  
Benjamin Leon Musher
Keyword(s):  
Colorectal Cancer ◽  
Health System ◽  
Cancer Care ◽  
Stage Iv ◽  
Safety Net ◽  
Financial Assistance ◽  
Comprehensive Cancer Center ◽  
Harris County ◽  
Assistance Program ◽  
Health Delivery

e18039 Background: Colorectal cancer (CRC) mortality has declined over the last three decades, but significant racial disparities in CRC survival continue to be reported, especially for stage IV disease. Hypothesizing that these disparities arise from differences in access to care rather than tumor biology, we examined treatment patterns and outcomes among minority patients evaluated and treated for stage IV CRC in an academic safety net health system. Methods: The Harris Health System is an integrated health delivery network that utilizes tax revenue to care for predominantly minority and uninsured residents of Harris County, Texas. As the largest Harris Health facility and an affiliate of the Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, Ben Taub Hospital delivers cancer care through multidisciplinary subspecialty clinics and a robust patient assistance program. We performed a retrospective analysis of minority patients diagnosed with stage IV CRC between 1/2010 and 12/2012 who were evaluated and treated at Ben Taub Hospital. Results: We identified 103 patients of whom 40% were black, 49% were Hispanic, and 12% were Asian or Middle Eastern. 65% spoke English as their preferred language; 74% were uninsured and covered by the Harris Health Plan, a financial assistance program for individuals with incomes under 300% of the federal poverty level. 85% of patients received cancer-directed therapy, of whom 99% received standard chemotherapy with a best response rate of 67% and a disease control rate of 87%. Median overall survival was 20.7 months for all patients and 23.0 months for patients who received chemotherapy. Conclusions: The Harris Health System provides the health delivery infrastructure through which minority patients with significant socioeconomic challenges obtain financial assistance and access to quality cancer care in an academic setting, thereby leading to clinical outcomes comparable to those of the predominantly Caucasian and insured populations studied in randomized control trials. Efforts to resolve disparities in CRC outcomes should focus on improving access of at-risk populations to comprehensive cancer care.

The converts and zakat distribution in state of Selangor

2017 ◽  
Vol 2 (1) ◽  
pp. 83-93
Author(s):  
Syarul Azman Shaharuddin ◽  
Zulkifli Abd Hamid ◽  
Fakhri Sungit
Keyword(s):  
Qualitative Study ◽  
Quantitative Study ◽  
Mixed Method ◽  
Financial Assistance ◽  
The Other ◽  
Assistance Program ◽  
Distribution Method ◽  
Assistance Programs ◽  
The One ◽  
The Right

The knowledge about zakat distribution method is a vital issue because it leaves an impact to the converts regarding fairness and satisfaction. The aim of the study is to analyze the zakat distribution method in the state of Selangor. In addition, the study is to delve the statisctics in the form of assistance programs received by the converts in Selangor. The study employs mixed method which adopts both quantitative and qualitative studies. The quantitative study employs the questionnaire instrument to 454 converts in Selangor. Meanwhile, the qualitative study employs the library study. The finding of the study indicates that there are twelve zakat distribution methods. The study also shows the statistics in the form of assistance program received by converts.There are fifteen forms of aid received by converts. In the one hand, the highest form of assistance program received by converts are hari raya allowance and monthly financial assistance which are amounted to 54.4% and 47.6% respectively. On the other hand, the lowest form of assistance program is printing and publication assistance which is amounted to 7%. The implication signifies that the zakat distribution method is dessiminated either in the form of money as well as services. Thus, the study finds that the zakat authority in Selangor has fairly distributed the funds into 1/8 of the right of zakat recipients.

scholarly journals Transparency of Industry-Sponsored Oncology Patient Financial Assistance Programs Using a Patient-Centered Approach

2017 ◽  
Vol 13 (3) ◽  
pp. e240-e248 ◽  
Author(s):  
S. Yousuf Zafar ◽  
Jeffrey Peppercorn ◽  
Akwasi Asabere ◽  
Alex Bastian
Keyword(s):  
Web Sites ◽  
Free Drug ◽  
Financial Assistance ◽  
Oncology Patient ◽  
Assistance Program ◽  
Specific Patient ◽  
Assistance Programs ◽  
Average Maximum ◽  
Patient Assistance ◽  
The Impact

Objective: Pharmaceutical manufacturers sponsor drug-specific patient assistance programs that provide eligible patients with financial assistance, either in the form of providing the drug free of charge or copayment assistance. Describing these programs and determining who receives assistance is an important first step in understanding the impact and role of financial assistance in cancer care. Our objective was to describe eligibility criteria and benefits for cancer-specific, manufacturer-sponsored patient assistance programs. Methods: We conducted a prospective review of patient assistance program Web sites and called patient assistance program telephone hotlines from the perspective of a patient or caregiver requesting program details. Results: We identified 24 manufacturers with patient assistance programs, covering 87% of Food and Drug Administration–approved oncology drugs. For free drug programs, the average maximum annual income for qualification was $86,279. For copayment assistance programs, the average was $104,790. Thirty-five percent of free drug programs and 53% of copayment assistance programs declined to provide details on how financial need was determined. None of the programs shared details on patient usage statistics. Conclusion: Variation exists in the quality and quantity of data available to patients seeking financial assistance for cancer treatment via manufacturer Web sites and hotlines. Greater transparency among patient assistance programs would enhance utility for patients and help to determine the net impact on costs and adherence.

Characterizing Out-of-Pocket Payments and Financial Assistance for Patients Prescribed Abiraterone and Enzalutamide at an Academic Cancer Center Specialty Pharmacy

2021 ◽  
pp. OP.21.00168
Author(s):  
Angelina Y. Jeong ◽  
Eric B. Schwartz ◽  
Andrea R. Roman ◽  
Rachel L. McDevitt ◽  
Mary K. Oerline ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Insurance Coverage ◽  
Financial Assistance ◽  
Cancer Center ◽  
Assistance Program ◽  
Time To Initiation ◽  
Out Of Pocket Payments ◽  
Specialty Pharmacy ◽  
Final Cohort ◽  
Out Of Pocket Costs

PURPOSE Abiraterone and enzalutamide are commonly used oral cancer therapies for patients with prostate cancer, both with potentially high out-of-pocket costs for patients. We investigated the prevalence of financial assistance mechanisms used to alleviate out-of-pocket costs and the association of these mechanisms with timing of treatment initiation of abiraterone or enzalutamide. METHODS Using data from the medical center's specialty pharmacy, we identified first prescriptions for abiraterone or enzalutamide between January 1, 2017, and March 31, 2019. Prescriptions dispensed at an external pharmacy or that were discontinued for reasons unrelated to cost were excluded. Patient demographics, insurance coverage, out-of-pocket cost, and number of days between prescribed date and pill-to-mouth date were collected. RESULTS Among 220 prescriptions in our final cohort, 185 were filled through our internal specialty pharmacy, 23 through a manufacturer-sponsored patient assistance program (PAP), and 12 were never filled because of cost. One third of the prescriptions in our final cohort (n = 66) were filled with financial assistance: PAP (10%), copay cards (9%), and grants (11%). The median amount of assistance received for the first fill was $2,860 US dollars (USD) (interquartile range $1,856-$10,717 USD). Prescriptions with an out-of-pocket cost < $100 USD were filled in the shortest time (median 5 days), whereas those filled through a PAP had the longest time to initiation (median 30.5 days). CONCLUSION Among patients prescribed oral therapies for prostate cancer at a single institution, one third of patients received financial assistance. Although receiving assistance is likely to improve financial toxicity, waiting for assistance may lead to longer time to initiation of medication.

Sign in / Sign up

Export Citation Format

Share Document